Common use of INCORPORATION OF INFORMATION BY REFERENCE Clause in Contracts

INCORPORATION OF INFORMATION BY REFERENCE. The SEC allows us to “incorporate by reference” the information we file with them which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus supplement and the accompanying prospectus. The information incorporated by reference is considered to be part of this prospectus supplement and the accompanying prospectus, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below (SEC File No. 001-39187) and any future filings made with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of this prospectus supplement and the termination of this offering (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items, unless otherwise indicated therein): • our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on December 1, 2023; • our Definitive Proxy Statement on Schedule 14A filed with the SEC on January 26, 2024 (solely to the extent incorporated by reference into Part III of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023); • our Quarterly Report on Form 10-Q for the quarter ended December 31, 2023, filed with the SEC on February 8, 2024; • our Current Reports on Form 8-K filed with the SEC on October 11, 2023, October 27, 2023, January 8, 2024, February 6, 2024 and March 13, 2024 (except that, with respect to each of the foregoing Current Reports, any portions thereof which are furnished and not filed shall not be deemed incorporated by reference into this prospectus supplement); • the description of our common stock contained in our Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on December 1, 2023, including any amendment or report filed for the purpose of updating such description; and • filings we make with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of the initial filing of the registration statement of which this prospectus supplement and the accompanying prospectus form a part and before the termination of the offering made by this prospectus supplement. We will provide to each person, including any beneficial owner, to whom a prospectus supplement and accompanying prospectus is delivered, without charge upon written or oral request, a copy of any or all of the documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectus, including exhibits which are specifically incorporated by reference into such documents. Requests should be directed to CleanSpark, Inc., Attn: Investor Relations, 00000 X. Xxxxxxx Xxx., Xxxxx X - 000, Xxxxxxxxx, NV 89052, telephone number (000) 000-0000 or email xx@xxxxxxxxxx.xxx. A statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement or the accompanying prospectus. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that was required to be stated or that was necessary to make a statement not misleading in light of the circumstances in which it was made. You should not assume that the information in this prospectus supplement, the accompanying prospectus or in the documents incorporated by reference is accurate as of any date other than the date of those respective documents.

INCORPORATION OF INFORMATION BY REFERENCE. The SEC allows SEC’s rules allow us to “incorporate by reference” the information we file with them into this prospectus, which means that we can disclose important information to you by referring you to those documents instead of having to repeat another document filed separately with the information in this prospectus supplement and the accompanying prospectusSEC. The information incorporated by reference is considered deemed to be part of this prospectus supplement and the accompanying prospectus, and later subsequent information that we file with the SEC will automatically update and supersede this that information. We incorporate Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement. This prospectus incorporates by reference the documents listed set forth below (SEC File No. 001that have previously been filed with the SEC: • our Annual Report on Form 10-39187) and any future filings made K for the year ended December 31, 2021, filed with the SEC under Sections onMarch 28, 2022; • our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022, filed with the SEC onMay 16, 2022, our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022, filed with the SEC on August 12, 2022, and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, filed with the SEC on November 14, 2022; • our Current Reports on Form 8-K filed with the SEC onMarch 2, 2022 (but only with respect to Item 5.02 thereto), June 10, 2022, July 15, 2022, and July 29, 2022. • the description of our common stock contained in our Registration Statement onForm 8-A filed with the SEC on December 2, 2020, as updated by the description of our common stock contained in Exhibit 4.6 to our Annual Report on Form 10-K for the year ended December 31, 2021, including any subsequent amendments or reports filed for the purpose of updating such description. All reports and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of in this prospectus supplement and prospectus, prior to the termination of this offering (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on offering, including all such form that are related to such items, unless otherwise indicated therein): • our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed documents we may file with the SEC on December 1, 2023; • our Definitive Proxy Statement on Schedule 14A filed with after the SEC on January 26, 2024 (solely date of the initial registration statement and prior to the extent incorporated by reference into Part III of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023); • our Quarterly Report on Form 10-Q for the quarter ended December 31, 2023, filed with the SEC on February 8, 2024; • our Current Reports on Form 8-K filed with the SEC on October 11, 2023, October 27, 2023, January 8, 2024, February 6, 2024 and March 13, 2024 (except that, with respect to each effectiveness of the foregoing Current Reportsregistration statement, but excluding any portions thereof which are information furnished and not to, rather than filed shall not with, the SEC, will also be deemed incorporated by reference into this prospectus supplement); • the description and deemed to be part of our common stock contained in our Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on December 1, 2023, including any amendment or report filed for the purpose of updating such description; and • filings we make with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after this prospectus from the date of the initial filing of the registration statement of which this prospectus supplement such reports and the accompanying prospectus form a part and before the termination of the offering made by this prospectus supplementdocuments. We will provide provide, without charge, to each person, including any beneficial owner, to whom a prospectus supplement and accompanying copy of this prospectus is delivered, without charge upon written or oral requestrequest of such person, a copy of any or all of the documents that are incorporated by reference into in this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectus, including other than exhibits which to such documents unless such exhibits are specifically incorporated by reference into such documents. Requests should may be directed to CleanSpark, Inc., Attn: Investor Relations, 00000 X. Xxxxxxx Xxx., Xxxxx X - 000, Xxxxxxxxx, NV 89052, made by telephone number at 0 (000) 000-0000 0000, or email xx@xxxxxxxxxx.xxx. A statement contained in by sending a document incorporated by reference herein shall be deemed written request to be modified or superseded for purposes hereof to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemedVelo3D, except as so modified or supersededInc., to constitute a part of this prospectus supplement or the accompanying prospectus. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement000 Xxxxxxxx Xxxxxx, when madeXxxxxxxx, constituted a misrepresentationXxxxxxxxxx 00000, an untrue statement of a material fact or an omission to state a material fact that was required to be stated or that was necessary to make a statement not misleading in light of the circumstances in which it was made. You should not assume that the information in this prospectus supplement, the accompanying prospectus or in the documents incorporated by reference is accurate as of any date other than the date of those respective documentsAttention: Investor Relations.

INCORPORATION OF INFORMATION BY REFERENCE. The SEC allows us to “incorporate by reference” the information that we file with them the SEC, which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus supplement and the accompanying prospectusother documents. The information incorporated by reference is considered to be an important part of this prospectus supplement and the accompanying prospectus, and later information that we file later with the SEC will automatically update and supersede this information. A Current Report (or portion thereof) furnished, but not filed, on Form 8-K shall not be incorporated by reference into this prospectus. We incorporate by reference the documents listed below (SEC File No. 001-39187) and any future filings made we make with the SEC under Sections Section 13(a), 13(c), 14 14, or 15(d) of the Exchange Act between the date of this prospectus supplement and prior to the termination of any offering of securities made by this offering (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items, unless otherwise indicated therein): prospectus: • our Annual Report on Form 10-K for the fiscal year ended September 30December 31, 20232019, filed with the SEC on December 1March 3, 2023; • our Definitive Proxy Statement on Schedule 14A filed with the SEC on January 26, 2024 (solely to the extent incorporated by reference into Part III of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023)2020; • our Quarterly Report Reports on Form 10-Q for the quarter quarters ended December March 31, 20232020 and June 30, 2020, filed with the SEC on February 8May 7, 20242020 and August 6, 2020, respectively; • our Current Reports on Form 8-K filed with the SEC on October 11January 21, 2023, October 27, 20232020, January 822, 20242020, February 6, 2024 2020, April 16, 2020, May 26, 2020, June 3, 2020, and March 13June 11, 2024 2020; • our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 24, 2020 (except that, but only with respect to each information required by Part III of our Annual Report on Form 10-K for the foregoing Current Reportsyear ended December 31, any portions thereof which are furnished and not filed shall not be deemed incorporated by reference into this prospectus supplement2019); • the description of our common stock contained in our registration statement on Form 8-A filed with the SEC on July 8, 2015 under Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description, including Exhibit 4.1 4.5 to our Annual Report on Form 10-K for the fiscal year ended September 30December 31, 20232019, filed with the SEC on December 1March 3, 2023, including any amendment or report filed for the purpose of updating such description2020; and • filings we make with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of the initial filing of the registration statement statement, of which this prospectus supplement is a part, and prior to the accompanying prospectus form a part and before the termination effectiveness of the offering made by this prospectus supplementregistration statement. We will provide to each person, including any beneficial owner, to whom a prospectus supplement and accompanying prospectus is delivered, furnish without charge upon to you, on written or oral request, a copy of any or all of the such documents that are has been incorporated herein by reference into this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectus, including (other than exhibits which to such documents unless such exhibits are specifically incorporated by reference into such documentsthe documents that this prospectus incorporates). Requests Written or oral requests for copies should be directed to CleanSparkSierra Oncology, Inc., Attn: Investor Relations, 00000 X. 0000 – 000 Xxxx Xxxxxxx Xxx., Xxxxx X - 000Xxxxxx, Xxxxxxxxx, NV 89052Xxxxxxx Xxxxxxxx, Xxxxxx X0X 0X0, and our telephone number is (000) 000-0000 or email xx@xxxxxxxxxx.xxx0000. A See the section of this prospectus entitled “Where You Can Find More Information” for information concerning how to obtain copies of materials that we file with the SEC. Any statement contained in this prospectus, or in a document document, all or a portion of which is incorporated by reference herein reference, shall be deemed to be modified or superseded for purposes hereof of this prospectus to the extent that a statement contained herein in this prospectus, any prospectus supplement or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemednot, except as so modified or superseded, to constitute a part of this prospectus supplement or the accompanying prospectus. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that was required to be stated or that was necessary to make a statement not misleading in light of the circumstances in which it was made. You should not assume that the information in this prospectus supplement, the accompanying prospectus or in the documents incorporated by reference is accurate as of any date other than the date of those respective documents.

INCORPORATION OF INFORMATION BY REFERENCE. The SEC allows us to “incorporate by reference” the information that we file with them the SEC, which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus supplement and the accompanying prospectusother documents. The information incorporated by reference is considered to be an important part of this prospectus supplement and the accompanying prospectus, and later information that we file later with the SEC will automatically update and supersede this information. A Current Report (or portion thereof) furnished, but not filed, on Form 8-K shall not be incorporated by reference into this prospectus. We incorporate by reference the documents listed below (SEC File No. 001-39187) and any future filings made we make with the SEC under Sections Section 13(a), 13(c), 14 14, or 15(d) of the Exchange Act between the date of this prospectus supplement and prior to the termination of any offering of securities made by this offering (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items, unless otherwise indicated therein): • prospectus: ∎ our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 30, 2023; ∎ our Quarterly Reports on Form 10-Q for the first three months ended March 31, 2023, filed with the SEC on May 15, 2023, for the six months ended June 30, 2023, filed with the SEC on August 10, 2023, and for the nine months ended September 30, 2023, filed with the SEC on December 1November 13, 2023; • ∎ our Current Reports on Form 8-K filed on January 9, 2023, February 24, 2023 , April 14, 2023 , April 27, 2023 , June 14, 2023 , June 26, 2023 , and October 4, 2023; ∎ our Definitive Proxy Statement on Schedule 14A 14A, filed with the SEC on January 26April 28, 2024 2023 (solely but only with respect to the extent incorporated information required by reference into Part III of our Annual Report on Form 10-K for the fiscal year ended September 30December 31, 2023); • 2022, which information shall update and supersede information included in Part III of our Quarterly Annual Report on Form 10-Q K for the quarter fiscal year ended December 31, 2023, filed with the SEC on February 8, 2024; • our Current Reports on Form 8-K filed with the SEC on October 11, 2023, October 27, 2023, January 8, 2024, February 6, 2024 and March 13, 2024 (except that, with respect to each of the foregoing Current Reports, any portions thereof which are furnished and not filed shall not be deemed incorporated by reference into this prospectus supplement2022); • and ∎ the description of our common stock contained in our registration statement on Form 8-A filed with the SEC on September 18, 2018 under Section 12 of the Exchange Act, as updated by Exhibit 4.1 4.5 to our Annual Report on Form 10-K for the fiscal year ended September 30December 31, 2023, filed with the SEC on December 1, 20232019, including any amendment or report filed for the purpose of updating such description; and • filings we make with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of the initial filing of the registration statement of which this prospectus supplement and the accompanying prospectus form a part and before the termination of the offering made by this prospectus supplement. We will provide to each person, including any beneficial owner, to whom a prospectus supplement and accompanying prospectus is delivered, furnish without charge upon to you, on written or oral request, a copy of any or all of the such documents that are has been incorporated herein by reference into this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectus, including (other than exhibits which to such documents unless such exhibits are specifically incorporated by reference into such documentsthe documents that this prospectus incorporates). Requests Written or oral requests for copies should be directed to CleanSparkSutro Biopharma, Inc., Attn: Investor Relations, 00000 X. Xxxxxxx Xxx000 Xxxxxx Xxxxx Xxxx., Xxxxx X - 000, Xxx Xxxxxxxxx, NV 89052Xxxxxxxxxx 00000, and our telephone number is (000) 000-0000 or email xx@xxxxxxxxxx.xxx0000. A See the section of this prospectus entitled “Where You Can Find More Information” for information concerning how to obtain copies of materials that we file with the SEC. Any statement contained in this prospectus, or in a document document, all or a portion of which is incorporated by reference herein reference, shall be deemed to be modified or superseded for purposes hereof of this prospectus to the extent that a statement contained herein in this prospectus, any prospectus supplement or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemednot, except as so modified or superseded, to constitute a part of this prospectus supplement or the accompanying prospectus. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that was required to be stated or that was necessary to make a statement not misleading in light of the circumstances in which it was made. You should not assume that the information in this prospectus supplement, the accompanying prospectus or in the documents incorporated by reference is accurate as of any date other than the date of those respective documents.

INCORPORATION OF INFORMATION BY REFERENCE. The SEC allows us to “incorporate by reference” the information we file with them it, which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus supplement and the accompanying prospectusdocuments. The information incorporated which we incorporate by reference is considered to be an important part of this prospectus supplement and the accompanying prospectus, and later certain information that we file later with the SEC will automatically update and supersede this information. We incorporate by reference the following documents listed below (SEC File No. 001-39187) 31938): • our Annual Report on Form 10-K for the year ended December 31, 2019, filed on February 28, 2020; • our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and any future filings made with the SEC under Sections September 30, 2020, filed on May 8, 2020, August 7, 2020 and November 6, 2020; respectively; and • our Current Reports on Form 8-K, filed on January 15, 2020, June 16, 2020, June 26, 2020, July 14, 2020, July 24, 2020, July 31, 2020, August 28, 2020, August 31, 2020, October 5, 2020, October 19, 2020, December 1, 2020, December 21, 2020, December 31, 2020 and January 13, 2021. In addition, all reports and other documents that we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act between prior to the date termination of this offering, but excluding any information furnished to, rather than filed with, the SEC, will be deemed to be incorporated by reference into this prospectus supplement and the accompanying prospectus and deemed to be part of this prospectus supplement and the termination accompanying prospectus from the time of this offering (other than Current Reports furnished under Item 2.02 or Item 7.01 the filing of Form 8-K such reports and exhibits filed on such form that are related to such items, unless otherwise indicated therein): • documents. You may access our Annual Report on Form 10-K for the fiscal year ended September 30K, 2023, filed with the SEC on December 1, 2023; • our Definitive Proxy Statement on Schedule 14A filed with the SEC on January 26, 2024 (solely to the extent incorporated by reference into Part III of our Annual Report Quarterly Reports on Form 10-K for the fiscal year ended September 30Q, 2023); • our Quarterly Report on Form 10-Q for the quarter ended December 31, 2023, filed with the SEC on February 8, 2024; • our Current Reports on Form 8-K filed with and amendments to any of these reports, free of charge on the SEC on October 11SEC’s website. Information contained on, 2023or that can be accessed through, October 27, 2023, January 8, 2024, February 6, 2024 and March 13, 2024 (except that, with respect to each our website is not part of the foregoing Current Reports, any portions thereof which are furnished and not filed shall not be deemed incorporated by reference into this prospectus supplement); • the description of our common stock contained in our Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on December 1, 2023, including any amendment or report filed for the purpose of updating such description; and • filings we make with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of the initial filing of the registration statement of which this prospectus supplement and the accompanying prospectus form a part and before the termination of the offering made by this prospectus supplementprospectus. We In addition, we will provide to each person, including any beneficial owner, to whom a prospectus supplement and accompanying prospectus is delivered, furnish without charge upon to you, on written or oral request, a copy of any or all of the documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectusreference, including other than exhibits which are specifically incorporated by reference into such to those documents. Requests You should be directed direct any requests for documents to CleanSparkCorporate Secretary, Acorda Therapeutics, Inc., Attn: Investor Relations000 Xxx Xxxx Xxxxx Xxxx, 00000 X. Xxxxxxx Xxx.Xxxxxxx, Xxxxx X - 000Xxx Xxxx 00000, Xxxxxxxxx, NV 89052, telephone number or call (000) 000-0000 0000. We are responsible for the information contained or email xx@xxxxxxxxxx.xxx. A statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement or the accompanying prospectus. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that was required to be stated or that was necessary to make a statement not misleading in light of the circumstances in which it was made. You should not assume that the information in this prospectus supplement, the accompanying prospectus and in any related free-writing prospectus we prepare or authorize. We have not authorized anyone to give you any other information, and we take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are not making offers to sell or seeking offers to buy these securities in any jurisdiction where the documents offer or sale is not permitted. You should assume that the information contained in or incorporated by reference in this prospectus supplement and the accompanying prospectus is accurate as of any date other than the date on the front of those respective documentsthis prospectus supplement, the accompanying prospectus or incorporated document only, as the case may be. Our business, financial condition, results of operations and prospects may have changed since that date.

INCORPORATION OF INFORMATION BY REFERENCE. The SEC allows us to “incorporate by reference” into this prospectus supplement and the accompanying prospectus information contained in documents that we file with them which it. This means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus supplement and the accompanying prospectusdocuments. The information incorporated by reference into this prospectus is considered to be an important part of this prospectus supplement and the accompanying prospectus, and later information that we file later with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below (SEC File No. 001-39187) and any future filings made we will make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act between prior to the date that the offering of the securities by means of this prospectus is completed or terminated, including all such documents we may file with the SEC after the date of this prospectus supplement the initial registration statement and prior to the termination effectiveness of this offering the registration statement (other than than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules, including Current Reports on Form 8-K furnished under Item 2.02 or Item 7.01 of Form 8-K and 7.01, including any financial statements or exhibits filed on such form that are related relating thereto furnished pursuant to such items, unless otherwise indicated thereinItem 9.01): • ● our Annual Report on Form 10-K for the fiscal year ended September 30December 31, 20232020, filed with the SEC on December 1February 25, 20232021; • our Definitive Proxy Statement on Schedule 14A filed with the SEC on January 26, 2024 (solely to the extent incorporated by reference into Part III of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023); • ● our Quarterly Report Reports on Form 10-Q for the quarter quarters ended December March 31, 20232021, June 30, 2021 and September 30, 2021, filed with the SEC on May 6, 2021, August 5, 2021 and November 4, 2021, respectively; ● our Current Reports on Form 8-K, filed with the SEC on February 25, 2021 (excluding such items as deemed furnished in such Form 8-K), 2024; • March 24, 2021, March 29, 2021, May 3, 2021, May 26, 2021, June 2, 2021, September 22, 2021, January 31, 2022 (excluding such items as deemed furnished in such Form 8-K), and February 14, 2022, and our Current Reports on Form 8-K K/A, filed with the SEC on October March 20, 2020, August 11, 20232020 and February 9, October 272022; ● our Definitive Proxy Statement on Schedule 14A, 2023filed with the SEC on March 29, January 8, 2024, February 6, 2024 and March 13, 2024 (except that, with respect to each of the foregoing Current Reports, any portions thereof which are furnished and not filed shall not be deemed incorporated by reference into this prospectus supplement)2021; • ● the description of our common stock contained in our Exhibit 4.1 to our Annual Report Registration Statement on Form 108-K for the fiscal year ended September 30, 2023, A filed with the SEC on December 1July 2, 20232014, including any amendment all amendments and reports filed for purposes of updating such description; ● the description of our Series A Preferred Stock contained in our Registration Statement on Form 8-A/A filed with the SEC on October 19, 2015, including all amendments or report reports filed for the purpose of updating such description; and • filings we make ● the description of our Series B Preferred Stock contained in our Registration Statement on Form 8-A filed with the SEC pursuant to Sections 13(a)on January 31, 13(c)2022, 14 including all amendments or 15(d) reports filed for the purpose of the Exchange Act after the date of the initial filing of the registration updating such description. Any statement of which incorporated by reference in this prospectus supplement and the accompanying prospectus form from an earlier dated document that is inconsistent with a part and before statement contained in this prospectus or in any other document filed after the termination date of the offering made by this prospectus supplement. We will provide earlier dated document, but prior to each personthe date hereof, including any beneficial owner, to whom a prospectus supplement and accompanying prospectus which also is delivered, without charge upon written or oral request, a copy of any or all of the documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectus, including exhibits which are specifically incorporated by reference into such documents. Requests should be directed to CleanSpark, Inc., Attn: Investor Relations, 00000 X. Xxxxxxx Xxx., Xxxxx X - 000, Xxxxxxxxx, NV 89052, telephone number (000) 000-0000 or email xx@xxxxxxxxxx.xxx. A statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a of this prospectus by such statement contained herein in this prospectus or in any other subsequently document filed document after the date of the earlier dated document, but prior to the date hereof, which also is or is deemed to be incorporated by reference herein modifies or supersedes such statementinto this prospectus. Any statement so modified or superseded shall not be deemedperson, except as so modified or supersededincluding any beneficial owner, to constitute a part whom this prospectus is delivered may request copies of this prospectus supplement or the accompanying prospectus. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include and any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that was required to be stated or that was necessary to make a statement not misleading in light of the circumstances in which it was made. You should not assume that the information in this prospectus supplement, the accompanying prospectus or in the documents incorporated by reference into this prospectus, without charge, by written or oral request directed to XxxxXxxxx, 0 Xxxxx Xxxx, Somerset, New Jersey, 08873, telephone: (000) 000-0000, x 133. Except as expressly provided above, no other information, including none of the information on our website, is accurate as of any date other than the date of those respective documentsincorporated by reference into this prospectus.

INCORPORATION OF INFORMATION BY REFERENCE. The SEC allows us to “incorporate by reference” the information we file with them it, which means that we can disclose important information to you by referring you to those documents instead of having to repeat the information in this prospectus supplement and the accompanying prospectusdocuments. The information incorporated we incorporate by reference is considered to be an important part of this prospectus supplement and the accompanying prospectus, and later certain information that we will later file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below (SEC File No. 001-39187) and below, as well as any future filings made with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act between from the date of the initial registration statement and prior to the effectiveness of this registration statement, and any filings made after the date of this prospectus supplement until we sell all of the securities under this prospectus, except that we do not incorporate any document or portion of a document that was furnished and deemed by the termination rules of this offering (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related the SEC not to such items, unless otherwise indicated therein): • our have been filed: ● Our Annual Report on Form 10-K for the fiscal year ended September June 30, 20232020, filed with the SEC on December 1September 28, 20232020; • our Definitive Proxy Statement on Schedule 14A filed with the SEC on January 26, 2024 (solely to the extent incorporated by reference into Part III of our Annual and ● Our Current Report on Form 10-K for the fiscal year ended September 30, 2023); • our Quarterly Report on Form 10-Q for the quarter ended December 31, 2023, filed with the SEC on February 8, 2024; • our Current Reports on Form 8-K filed with the SEC on October 111, 2023, October 27, 2023, January 8, 2024, February 6, 2024 2020; and March 13, 2024 (except that, with respect to each of the foregoing Current Reports, any portions thereof which are furnished and not filed shall not be deemed incorporated by reference into this prospectus supplement); • the ● The description of our common stock contained set forth in Item 1 of our Exhibit 4.1 to our Annual Report Registration Statement on Form 108-K for A filed on August 6, 2020, pursuant to Section 12(b) of the fiscal year ended September 30, 2023, filed with the SEC on December 1, 2023Exchange Act, including any amendment or report filed for the purpose of updating such description; . Additionally, all reports and • filings we make with the SEC other documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or and 15(d) of the Exchange Act after the effective date of this prospectus and prior to the initial termination or completion of this offering, shall be deemed to be incorporated by reference in this prospectus and to be part hereof from the date of filing of such reports and other documents. Any information that we subsequently file with the registration statement SEC that is incorporated by reference as described above will automatically update and supersede any previous information that is part of which this prospectus supplement and the accompanying prospectus form a part and before the termination of the offering made by this prospectus supplementprospectus. We will hereby undertake to provide without charge to each person, including any beneficial owner, to whom a prospectus supplement and accompanying copy of this prospectus is delivered, without charge upon written or oral requestrequest of any such person, a copy of any or and all of the documents information that are has been or may be incorporated by reference into in this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying prospectus, including other than exhibits which are specifically incorporated by reference into to such documents. Requests for such copies should be directed to CleanSpark, Inc., Attn: Investor Relations, 00000 our Secretary at 0000 X. Xxxxxxx Xxx.Xxxxx, Xxxxx X - 000XX, Xxxxxxxxx, NV 89052, telephone number 00000; Telephone (000) 000-0000 or email xx@xxxxxxxxxx.xxx. A statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement or the accompanying prospectus. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes. The making of such a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that was required to be stated or that was necessary to make a statement not misleading in light of the circumstances in which it was made. You should not assume that the information in this prospectus supplement, the accompanying prospectus or in the documents incorporated by reference is accurate as of any date other than the date of those respective documents0000.